Role of the Immune Environment in Response to Therapy in Breast Cancer
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Women 18 years of age or older with non-metastatic breast cancer undergoing surgical resection in the University of Pennsylvania Health System.
Locations
United States
Pennsylvania
Abramson Cancer Center
RECRUITING
Philadelphia
Contact Information
Primary
Julia T. Lewandowski
Julia.Lewandowski@Pennmedicine.upenn.edu
215-662-2861
Backup
Jennifer Zhang, MD
Jennifer.Zhang@Pennmedicine.upenn.edu
215-615-6810
Time Frame
Start Date: 2022-10-03
Estimated Completion Date: 2032-12-31
Participants
Target number of participants: 300
Related Therapeutic Areas
Sponsors
Leads: Abramson Cancer Center at Penn Medicine